TyraTech, Inc. Vamousse now distributed by CVS in the USA (3546I)
March 25 2015 - 2:00AM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 3546I
TyraTech, Inc.
25 March 2015
TyraTech, Inc.
("TyraTech" or the "Company")
Vamousse(R) head lice treatment now distributed by CVS in the
USA
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company
focused on nature-derived insect and parasite control products, is
pleased to announce that it has secured listings for its Vamousse
Treatment product with the CVS Pharmacy Group in the USA.
CVS Pharmacy
CVS Pharmacy is the second largest pharmacy chain after
Walgreens in the United States, with more than 7,600 stores and 100
million American customers each year. This listing, which follows
the recent announcement of deals with the top three pharmaceutical
distributors in the USA, represents a further key milestone for the
roll-out of TyraTech's Vamousse products in America. It is expected
that the Treatment product will be available in the majority of CVS
stores nationwide in the USA from the end of April 2015.
Tesco update
In addition to the progress in the USA, we are pleased to
announce positive developments in our UK distribution network also.
Tesco, which had until recently been selling the Vamousse Treatment
product through its pharmacy counters, will also place the product
into open shelving, making it more accessible and visible to
customers. Tesco has also confirmed separately, that it will almost
double the number of stores stocking TyraTech's Vamousse Treatment
product.
Bruno Jactel, Chief Executive Officer, said: "The CVS listing is
probably our most important milestone this year as it firmly
establishes our product in the pharmacy segment in the USA and
significantly enhances the profile of our brand. I would like to
thank our partner, the Greenwood Group, which has been instrumental
in establishing the commercial relationship with CVS and our retail
partners in the USA. Together with the recent announcement of the
three biggest pharmaceutical distributors in the USA, and Lloyds
and Day Lewis in the UK, we are very excited by the growth
opportunities presented by the continually expanding distribution
network for Vamousse products."
Further information on Vamousse(R) is available on the Company's
website at http://www.vamousselice.com/
TyraTech Inc.
Bruno Jactel, Chief Executive Tel: +1 919
Officer 415 4340
Vince Morgus, Chief Financial Tel: +1 919
Officer & Treasurer 415 4287
SPARK Advisory Partners Limited, Tel: +44203
Nominated Adviser 368 3552
Matt Davis / Mark Brady Tel: +44203
368 3551
Allenby Capital Limited ,
Joint Broker Tel: +44 20
Chris Crawford 3328 5656
Whitman Howard Limited, Joint
Broker Tel: +44 20
Ranald Mc-Gregor Smith / 7659 1240
Niall Devins
Walbrook, Financial PR and
IR Tel: +44 20
Nick Rome /Guy McDougall 7933 8790
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBLGDXSSDBGUS
Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024